Tembeling 2.0

Tag: public health

  • Act 852 and the future of nicotine control in Malaysia

    Introduction

    The Control of Smoking Products for Public Health Act 2024 (Act 852) marks a decisive shift in Malaysia’s public health policy. It represents a progression from the previous regulatory framework, where smoking control was largely governed under the Food Act 1983 through the Control of Tobacco Product Regulations 2004. That earlier approach focused primarily on conventional cigarettes and treated tobacco as a regulated consumer product within a broader food and safety context.

    Act 852 moves beyond this limitation by establishing a dedicated public health law for smoking and nicotine control, recognising that the current landscape includes not only cigarettes but also vaping, substitute tobacco products and evolving nicotine delivery systems. The Act came into operation on 1 October 2024, marking the transition to this new regulatory framework.

    What distinguishes Act 852 is its recognition that nicotine use today is no longer confined to cigarettes. It therefore regulates not only products, but also delivery systems, access, environments and market behaviour.

    The strength of the Act

    A whole-system regulatory framework

    The strength of Act 852 lies in its integrated, system-level approach. It regulates access and availability, including prohibition of online sales, vending machines and sales near educational institutions (Control of Smoking Products for Public Health (Control of Sale) Regulations 2024, P.U. (A) 260). It also regulates public exposure through the declaration of no-smoking areas covering healthcare facilities, eating premises and transport hubs (Control of Smoking Products for Public Health (Declaration of Non-Smoking Area or Place) Order 2024, P.U. (A) 257).

    Risk perception is strengthened through packaging, labelling and the prohibition of misleading descriptors such as “light” or “mild” (Control of Smoking Products for Public Health (Packaging and Labelling) Regulations 2024, P.U. (A) 261). Market control is introduced through product registration, laboratory analysis and traceability (Control of Smoking Products for Public Health (Registration of Tobacco Product, Smoking Substance and Substitute Tobacco Product) Regulations 2024, P.U. (A) 262). Enforcement mechanisms are also strengthened through compounding of offences and structured notice procedures (Control of Smoking Products for Public Health (Compounding of Offences) Regulations 2024, P.U. (A) 259).

    This multi-layered approach ensures that control is not limited to individual behaviour, but extends to the entire ecosystem.

    Controlling nicotine and addiction

    A defining feature of Act 852 is the direct regulation of nicotine, particularly for vape products. The law introduces measurable limits under the Packaging and Labelling Regulations 2024 (P.U. (A) 261, regulation 9):

    • Maximum nicotine concentration of 35 mg/ml, reduced to 20 mg/ml from 1 October 2025
    • Maximum cartridge or pod volume of 3 ml, reduced to 2 ml from 1 October 2026

    This shifts policy from simply discouraging smoking to actively controlling addiction potential.

    Regulating both cigarettes and vape

    Act 852 is unique in that it regulates both combustible and non-combustible nicotine products within the same legal framework. Cigarettes are addressed as established harmful products to be reduced, while vape is regulated as a system comprising both device and content.

    The content is tightly controlled through nicotine limits, packaging and product registration. The device is controlled indirectly through restrictions on sale, use and linkage to regulated substances.

    Progress of enforcement

    Scale of enforcement

    The early phase of implementation demonstrates strong nationwide enforcement. Reported figures include:

    • More than 25,000 enforcement operations conducted
    • Nearly 500,000 premises inspected
    • Over 140,000 notices issued
    • More than 20,000 compounds issued to premises owners
    • Thousands of products seized and investigation papers opened

    These figures indicate that Act 852 is already being implemented at scale, with enforcement extending beyond pilot phases to a national level.

    Enforcement across multiple domains

    Enforcement is not confined to smokers alone, but spans multiple levels. Public smoking control is implemented particularly in restaurants, healthcare settings and public places, reflecting enforcement of no-smoking areas (P.U. (A) 257). Premises accountability is strengthened where owners must display warning signs and ensure compliance (Control of Smoking Products for Public Health (Warning Sign of Prohibition of Smoking) Regulations 2024, P.U. (A) 258).

    Retail and supply control includes prohibition of online sales, vending machines and sales near educational institutions (P.U. (A) 260). Product regulation includes enforcement against non-compliant or unregistered products (P.U. (A) 262). Legal enforcement mechanisms include compounding and prosecution (P.U. (A) 259).

    The pattern of enforcement suggests that behavioural enforcement is already strong and visible, retail and premises compliance is actively enforced, and product and vape-related regulation is emerging and will require continued strengthening.

    Long-term impact and how to measure it

    A nicotine-free generation

    The most important long-term outcome is the prevention of nicotine dependence among future generations. This is supported by reduced access and restrictions on sales channels, especially online sales, vending machines and sales near educational institutions (P.U. (A) 260).

    Denormalisation of smoking and vaping

    The expansion of no-smoking areas and the requirement to display warning signs aim to reduce visibility and social acceptability of smoking and vaping (P.U. (A) 257; P.U. (A) 258).

    Reduction in nicotine dependence

    The explicit control of nicotine concentration and product volume is expected to reduce addiction intensity at the population level (P.U. (A) 261).

    Elimination of misleading product perception

    Strict packaging and labelling controls ensure that no product is perceived as safe or less harmful. This is particularly important for both cigarettes and vape, where descriptors and product design may create false reassurance (P.U. (A) 261).

    A controlled product ecosystem

    Registration and laboratory analysis ensure that products are traceable and regulated, reducing the presence of illegal or non-compliant products (P.U. (A) 262).

    Measuring success

    Success should be assessed through:

    • Reduction in smoking and vaping prevalence, especially among youth
    • Increase in age of initiation
    • Reduction in exposure to second-hand smoke and aerosol
    • Compliance with no-smoking areas and sales restrictions
    • Reduction in illegal or non-compliant products
    • Increase in quit attempts and utilisation of cessation services
    • Long-term decline in tobacco-related disease burden

    The role of other laws and organisations

    Act 852 does not operate in isolation. Vape regulation in Malaysia requires a coordinated legal and institutional ecosystem because vape is not only a public health issue, but also a chemical product, an electronic device, a traded commodity and a digitally marketed item. As such, multiple laws and agencies contribute to its regulation across different domains.

    Substance control

    The Poisons Act 1952 (Act 366) historically regulated nicotine in liquid form as a controlled substance. While nicotine used in vape liquids has since been exempted to allow regulation under Act 852, the Poisons Act remains relevant for broader chemical control and for situations where substances may fall within pharmaceutical or toxicological oversight.

    In addition, the Sale of Drugs Act 1952 and related regulations may apply if nicotine-containing products are positioned as therapeutic or smoking cessation aids. In such cases, these products would be subject to pharmaceutical standards and regulatory approval.

    Importation and border control

    The Customs Act 1967 (Act 235) plays a critical role in controlling the entry of vape devices and liquids into Malaysia. It enables enforcement authorities to:

    • monitor importation of vape products and components
    • seize undeclared, illegal or non-compliant products
    • prevent smuggling and illicit trade

    This is essential because a significant proportion of vape products are imported and may bypass domestic regulatory requirements without effective border control.

    Consumer safety and product liability

    The Consumer Protection Act 1999 (Act 599) governs product safety and liability. Vape devices, being electronic consumer products, fall within its scope. This Act is particularly relevant for:

    • defective or unsafe devices
    • battery failures, overheating or explosion risks
    • consumer rights and compensation

    While Act 852 regulates how vape is used and sold, the Consumer Protection Act ensures that the products themselves do not pose undue risk to users.

    Trade, pricing and affordability

    The Sales Tax Act 2018 (Act 806) and excise duty frameworks influence the pricing of vape products and tobacco. Pricing remains one of the most effective public health tools, particularly in reducing youth access and consumption.

    In addition, the Trade Descriptions Act 2011 (Act 730) addresses false or misleading commercial claims. While Act 852 already prohibits misleading labelling for smoking products, this Act extends protection to broader marketing practices across commercial platforms.

    Digital marketing and online content

    The Communications and Multimedia Act 1998 (Act 588) regulates online content, advertising and digital communications. This is particularly relevant for vape products, which are often promoted through:

    • social media platforms
    • influencer marketing
    • online retail channels

    Control of digital exposure is essential, especially in protecting adolescents and young adults from targeted marketing.

    Retail environment and local enforcement

    Under the Local Government Act 1976 (Act 171), local authorities have powers over licensing and business premises. This allows them to:

    • regulate the location and density of vape and tobacco retailers
    • enforce local compliance with no-smoking areas
    • support on-the-ground enforcement of Act 852

    Local authorities therefore play a key role in translating national policy into community-level implementation.

    Device safety and technical standards

    Vape devices are electrical and electronic products, and their safety is not fully addressed under Act 852. This is where technical agencies play an important role.

    The Standards of Malaysia Act 1996 (Act 549), through SIRIM, provides the framework for developing and enforcing technical standards. SIRIM can contribute by establishing standards for:

    • battery safety and charging systems
    • device construction and material safety
    • quality assurance and manufacturing consistency

    In addition, the Electricity Supply Act 1990 (Act 447), enforced by the Energy Commission, ensures compliance with electrical safety requirements for devices.

    This technical layer is especially important for open-system devices, which are more variable and modifiable, and therefore present greater safety and regulatory challenges.

    Integrated regulatory ecosystem

    Taken together, these laws form a coordinated system:

    • Act 852 – public health, access, use and nicotine control
    • Poisons Act and Sale of Drugs Act – substance and therapeutic regulation
    • Customs Act – importation and border control
    • Consumer Protection Act – device safety and liability
    • Trade and tax laws – pricing and commercial conduct
    • Communications and Multimedia Act – digital marketing and exposure
    • Local Government Act – retail environment and local enforcement
    • SIRIM and technical laws – device standards and safety

    The effectiveness of Act 852 therefore depends not only on its own provisions, but on how well these complementary laws and agencies work together to regulate the full spectrum of nicotine products.

    In this context, vape regulation is best understood not as a single law issue, but as a multi-sector public health system requiring coordinated governance across health, trade, technology and enforcement domains.

    Conclusion

    Act 852 represents Malaysia’s transition from tobacco control under the Food Act framework to a dedicated, comprehensive nicotine control law. Its strength lies in regulating both products and systems, including measurable limits on nicotine exposure and comprehensive control of access, environment and market behaviour.

    Its success will depend on sustained enforcement, coordination across agencies and complementary roles from technical bodies such as SIRIM. Over time, the impact will be reflected in reduced initiation, lower dependence, declining prevalence and ultimately a reduction in the burden of tobacco-related disease.

  • When population health is no longer a priority

    https://jamanetwork.com/journals/jama/fullarticle/2846529

    The recent Perspective article in JAMA raises a deeply unsettling argument. The problem facing population health is no longer simply neglect. It is the growing possibility that policy decisions themselves are beginning to work against health.

    The authors describe how, over the past decade, the United States has already experienced stagnation and even decline in key health indicators such as life expectancy. This was not unexpected. For years, public health experts had pointed to the structural determinants that shape health outcomes, including access to healthcare, socioeconomic inequality, education, environmental exposures, and the strength of public health institutions.

    The solutions were not unknown. Expand access to care. Strengthen social protection. Regulate harmful industries. Invest in science and public health systems. Address inequality. These are long-established principles supported by evidence.

    What is new, and concerning, is the shift away from these solutions. The article argues that recent policy directions have not merely failed to improve population health but may actively undermine it. Reductions in support for scientific research weaken the evidence base that informs policy. Erosion of public health protections reduces the ability to prevent harm before it occurs. Policies that increase social and economic vulnerability widen health inequities.

    In this framing, worsening population health is no longer an unintended consequence. It becomes predictable. When policies disregard the foundations of health, outcomes follow accordingly.

    This perspective invites reflection beyond the United States.

    In Malaysia, several structural signals warrant attention.

    First, the burden of disease is already high. Malaysia has one of the highest prevalences of obesity in Asia, accompanied by a growing burden of non-communicable diseases. This reflects sustained exposure to behavioural and environmental risks, particularly dietary patterns that are deeply embedded in daily life.

    Second, the healthcare system is under strain. Workforce challenges, including shortages, migration, and burnout, are increasingly evident. A constrained workforce limits the system’s ability to balance curative services with preventive and public health functions, shifting focus towards short-term demand rather than long-term health outcomes.

    Third, there are gaps in policy and enforcement related to known health risks. Tobacco control, including the regulation of e-cigarettes, remains an area of concern. Reluctance to implement and enforce stronger measures risks sustaining nicotine dependence and enabling new patterns such as dual use, particularly among younger populations.

    These are not isolated issues. They represent interconnected elements within the broader population health landscape.

    The concern is not that Malaysia is currently adopting policies that directly undermine health. Rather, it is the possibility that, without decisive and sustained action, existing conditions, cultural norms, and policy hesitations may collectively produce similar effects.

    The lesson from the JAMA article is clear. Population health is shaped by policy choices. When health is not consistently prioritised across sectors, deterioration becomes a foreseeable outcome rather than an unexpected one.

    Malaysia remains at a point where the trajectory can still be shaped. Recognising these signals early allows for a more deliberate response, ensuring that population health remains central in policy and practice, rather than becoming an afterthought.

  • A principled perspective on the roles of Public Health Medicine Specialists and PTD officers in the Ministry of Health

    The discussion on whether Public Health Medicine Specialists (PPKA) can replace or assume roles currently held by PTD officers must be framed correctly. It is not fundamentally a question of replacement, but rather a question of role alignment, competency utilisation, and leadership development within a complex health system. Any modern health system functions best when professional expertise and administrative competence complement each other, not when one is viewed as substituting entirely for the other.

    The foundational principle of professional and administrative competence

    A key principle in organisational leadership, particularly in highly specialised sectors such as healthcare, is that it is generally easier to train a technical expert in administrative and management functions than to train a general administrator to acquire deep professional and technical expertise. This is because professional training in medicine and public health requires many years of structured education, supervised practice, and competency development. Public Health Medicine Specialists undergo rigorous training through Master’s and often Doctor of Public Health programmes, covering epidemiology, health systems, health policy, programme planning, management, and evaluation. Their training inherently integrates management principles within the context of health systems, rather than management in isolation.

    In contrast, PTD officers enter the civil service with diverse academic backgrounds, often without specific training in healthcare, epidemiology, or health systems. However, they bring valuable strengths in governance, administrative procedures, finance, policy implementation, and organisational coordination. These competencies are essential for the functioning of large institutions such as the Ministry of Health. Their role is therefore complementary, not inferior nor superior, but different in nature.

    The unique training and competency of Public Health Medicine Specialists

    Public Health Medicine Specialists are uniquely trained to understand the health system as a whole. Their competencies include disease surveillance, epidemiological analysis, programme planning, prevention and control strategies, health policy development, and health system evaluation. Importantly, their training also includes management and leadership within healthcare settings. They are trained not only to analyse disease patterns but also to design and implement interventions at population level, coordinate services across sectors, and evaluate outcomes.

    This gives them a critical advantage when making decisions that directly affect health service delivery, disease prevention, and population health outcomes. Their decisions are informed by both scientific evidence and operational realities. For example, an epidemiologist overseeing disease surveillance does not merely analyse data but plans preventive strategies, allocates resources based on risk, and coordinates responses across multiple levels of the health system.

    Their management training is therefore context-specific. It is grounded in healthcare realities, which makes them particularly suited for leadership roles that require integration of clinical, preventive, and system perspectives.

    The appropriate positioning of Public Health Medicine Specialists within the health system

    Public Health Medicine Specialists should primarily be recognised and positioned as specialists, equivalent in professional standing to clinicians in hospitals. Just as clinicians lead clinical services based on their expertise, Public Health Medicine Specialists should lead technical areas such as disease surveillance, prevention programmes, health policy planning, and population health strategy.

    Many specialists, whether clinical or public health, naturally progress into administrative and leadership roles as part of their career development. Their technical background strengthens their administrative effectiveness because their decisions are grounded in real-world professional experience. This is consistent with the model seen globally, where healthcare organisations are often led by individuals with professional training in medicine or public health, supported by administrative professionals.

    However, this does not mean that all specialists must become administrators. Many should remain focused on technical leadership, which is essential for maintaining the integrity and effectiveness of health programmes.

    The continued relevance and complementary role of PTD officers

    PTD officers play an important role in supporting the health system. Their expertise in public administration, finance, human resource management, and policy implementation (if they really have the expertise) provides essential organisational support. They facilitate the operational and administrative processes that allow technical specialists to focus on professional and programme leadership.

    Rather than viewing the roles as interchangeable, it is more accurate to view them as complementary. PTD officers can support specialists by managing administrative systems, while specialists provide technical direction and professional leadership. This collaborative model ensures both administrative efficiency and technical excellence.

    Leadership roles must be determined by competency, not professional category alone

    Leadership is not automatically determined by whether an individual is a Public Health Medicine Specialist or a PTD officer. Leadership requires specific competencies including strategic thinking, decision-making, communication, integrity, and the ability to guide organisations effectively. These competencies must be developed over time through training and experience.

    Not all specialists are suited for leadership roles, and not all administrators are suited for technical leadership roles. Both groups require leadership development if they are to assume senior management positions. The key principle is that leadership roles must be assigned based on demonstrated competency, relevant experience, and suitability, rather than professional designation alone.

    Where leadership involves technical decision-making related to health systems, disease control, or service planning, individuals with professional health expertise have a natural advantage because they understand the implications of decisions at both clinical and population levels.

    The relationship between directors, deputies, and administrative leadership

    In many healthcare systems, directors provide strategic and professional leadership, while deputies support operational coordination, administrative implementation, and organisational management. When deputies have professional health expertise, this can strengthen decision-making by ensuring that operational and administrative decisions align closely with technical realities.

    However, administrative expertise remains essential. Administrative officers provide continuity, governance, and procedural oversight, ensuring that organisational systems function efficiently.

    The most effective model is therefore one where technical leadership and administrative expertise work in partnership.

    Leadership at the Ministry level and the distinction between administrative and technical leadership

    At the highest levels, such as the Secretary-General and Deputy Secretary-General positions, leadership involves national-level policy implementation, resource allocation, organisational coordination, and governance. These roles require strong administrative and leadership competencies, as well as an understanding of the health system.

    Whether such roles are held by individuals with health professional training or administrative training depends on their competency, experience, and leadership capability. Individuals with public health expertise bring strong understanding of health systems and population health, while those with administrative training bring strengths in governance, policy coordination, and organisational management.

    Both backgrounds can contribute effectively if the individual possesses the required leadership and management competencies.

    Conclusion

    The issue is not whether Public Health Medicine Specialists should replace PTD officers, but how both groups should be optimally positioned to strengthen the health system. Public Health Medicine Specialists should be recognised as professional specialists with leadership roles in technical and health system domains, equivalent in standing to clinical specialists. PTD officers should continue to provide essential administrative and governance support.

    Leadership roles should be determined based on competency, experience, and suitability, not solely professional designation. Both specialists and administrators have important roles, and the most effective health system is one where professional expertise and administrative competence work together in a coordinated and complementary manner.

    This approach ensures that decisions affecting health services and population health are both technically sound and administratively effective, ultimately strengthening the overall performance of the Ministry of Health.

  • PrEP Must Be Implemented with Mandatory Behavioural Intervention

    From a public health perspective, harm reduction is not confined to lowering biological risk alone. It must also address the behaviours that generate that risk. While HIV pre-exposure prophylaxis, or PrEP, is effective in reducing the probability of HIV transmission, it does not modify sexual risk behaviour and cannot replace personal responsibility or behavioural change.

    From the standpoint of the Health Belief Model, behaviour is strongly influenced by an individual’s perceived susceptibility and perceived severity of harm. When PrEP is introduced without structured behavioural intervention, it may substantially reduce the perceived risk of HIV transmission. This lowered perception of harm weakens the motivation to change behaviour, resulting in the continuation, or even escalation, of high-risk sexual practices. In this context, PrEP risks undermining the behavioural drivers essential for sustainable prevention.

    When PrEP is promoted without mandatory and structured behavioural interventions, it ceases to function as genuine harm reduction and instead becomes a mechanism that enables the continuation of unhealthy and high-risk sexual behaviours under the false assurance of biomedical protection. This represents a shift from prevention to harm containment, which is inconsistent with established public health principles.

    Beyond biomedical and behavioural considerations, public health interventions must also recognise the moral, ethical, and spiritual dimensions of human behaviour. For Muslim communities in particular, health promotion should not be detached from faith. Islam emphasises accountability before God, moral conduct, self-restraint, and the pursuit of what is good and beneficial for oneself and society. Prevention strategies should therefore encourage individuals not only to avoid harm, but also to return to values grounded in belief in God and commitment to doing good.

    Crucially, HIV prevention and control cannot be addressed by the Ministry of Health alone. It requires a deliberate, coordinated, and sustained multi-agency approach. Ministries responsible for education, youth and sports, higher education, religious affairs, social welfare, women and family development, as well as law enforcement, community leaders, religious institutions, non-governmental organisations, and families must all share responsibility. Behaviour, values, and social norms are shaped far beyond the healthcare system, and ignoring this reality weakens any national response.

    The provision of PrEP must therefore be embedded within a comprehensive and structured prevention framework that is multi-sectoral by design. This includes rigorous behavioural risk assessment prior to initiation, continuous sexual health counselling, reinforcement of safer practices, adherence monitoring, and periodic reassessment of ongoing need, supported by education, moral guidance, and community engagement across multiple agencies. Without these elements, the use of PrEP risks normalising sustained high-risk behaviour and may contribute to rising rates of other sexually transmitted infections.

    A relevant comparison is nicotine replacement therapy. Nicotine patches are never offered in isolation. They are part of structured cessation programmes with counselling, monitoring, and a clear objective of stopping smoking. PrEP, in contrast, is too often framed as a long-term biomedical solution without a defined behavioural trajectory or exit strategy. This difference is significant and must be addressed in policy and implementation.

    If the Ministry of Health advocates PrEP as part of the national HIV prevention strategy, it carries a responsibility to ensure that its delivery is ethically sound, behaviourally anchored, and evidence informed. Biomedical tools must support behavioural change, moral responsibility, and ethical reflection, not substitute for them, and this must be reinforced through coordinated action across agencies.

    PrEP can play a role in HIV prevention, but only as an adjunct within a structured, monitored, behaviour-focused, values-conscious, and genuinely multi-agency strategy. Sustainable HIV control will not be achieved through medication alone. Behavioural modification, ethical responsibility, moral guidance, and shared societal accountability remain central and must be treated as non-negotiable components of any effective national HIV prevention programme.